WEBCAST: The Impact of the COVID-19 Pandemic on Early Phase Clinical Trials
Wednesday, 9 June 2021
10am EDT / 3pm BST / 4pm CEST
The COVID-19 pandemic posed and still poses unprecedented challenges on all stages of clinical trials. Regulatory agencies published guidance on how to manage clinical trials, stating that priority was to be given to COVID-19 studies, slowing down and halting non-COVID-19 trials.
The pandemic has forced all stakeholders to think outside the box and beyond their comfort zone.
Both our Clinical Pharmacology Unit and Clinical Operations will give you an insight into how they handled this unforeseen situation. Hear why it is important to be flexible and learn quickly in order to be able to (re)start trials under implementation of a strict COVID-19 risk mitigation plan, and minimize viral spread and impact on safety or data quality.